Brawn Biotech Share Price
Start SIP in Brawn Biotech
Start SIPBrawn Biotech Performance
Day Range
- Low 0
- High 0
52 Week Range
- Low 0
- High 0
- Open Price0
- Previous Close0
- Volume
Brawn Biotech Investment Rating
-
Master Rating:
-
Brawn Biotech has an operating revenue of Rs. 13.27 Cr. on a trailing 12-month basis. An annual revenue de-growth of -25% needs improvement, Pre-tax margin of -9% needs improvement, ROE of -30% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 11 which is a POOR score indicating inconsistency in earnings, a RS Rating of 9 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 47 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 4 | 3 | 3 | 3 | 7 | 5 |
| Operating Expenses Qtr Cr | 5 | 4 | 3 | 3 | 7 | 5 |
| Operating Profit Qtr Cr | -1 | 0 | -1 | 0 | 0 | 0 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | -1 | 0 | -1 | 0 | 0 | -1 |
Brawn Biotech Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 15
- Bearish Moving Average
- ___
- 1
- 20 Day
- ₹20.25
- 50 Day
- ₹20.47
- 100 Day
- ₹20.64
- 200 Day
- ₹20.25
- 20 Day
- ₹20.30
- 50 Day
- ₹19.96
- 100 Day
- ₹21.24
- 200 Day
- ₹20.26
Brawn Biotech Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 21.21 |
| Second Resistance | 21.23 |
| Third Resistance | 21.23 |
| RSI | 55.60 |
| MFI | 53.02 |
| MACD Single Line | 0.05 |
| MACD | 0.02 |
| Support | |
|---|---|
| First Support | 21.19 |
| Second Support | 21.19 |
| Third Supoort | 21.17 |
Brawn Biotech Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 15,373 | 1,517,161 | 98.69 |
| Week | 7,248 | 679,526 | 93.76 |
| 1 Month | 5,202 | 434,323 | 83.49 |
| 6 Month | 2,123 | 181,039 | 85.26 |
Brawn Biotech Result Highlights
Brawn Biotech Synopsis
BSE-Medical-Generic Drugs
Brawn Biotech is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 22.23 Cr. and Equity Capital is Rs. 3.00 Cr. for the Year ended 31/03/2023. Brawn Biotech Ltd. is a Public Limited Listed company incorporated on 07/11/1985 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1985PLC022468 and registration number is 022468.| Market Cap | 6 |
| Sales | 13 |
| Shares in Float | 0.14 |
| No of funds | 1 |
| Yield | 3.13 |
| Book Value | 1.2 |
| U/D Vol ratio | 0.6 |
| LTDebt / Equity | |
| Alpha | -0.01 |
| Beta | 0.21 |
Brawn Biotech Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 53.64% | 53.64% | 53.72% | 53.72% |
| Mutual Funds | 0.35% | 0.35% | 0.59% | 0.59% |
| Individual Investors | 33.96% | 33.91% | 42.9% | 42.89% |
| Others | 12.05% | 12.1% | 2.79% | 2.8% |
Brawn Biotech Management
| Name | Designation |
|---|---|
| Mr. Brij Raj Gupta | Chairman |
| Mrs. Brij Bala Gupta | Director |
| Mr. Subhash Chander | Independent Director |
| Mrs. Kanta Takkar | Independent Director |
Brawn Biotech Forecast
Price Estimates
Brawn Biotech Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-14 | Quarterly Results | |
| 2024-05-29 | Audited Results | |
| 2024-02-14 | Quarterly Results | |
| 2023-11-10 | Quarterly Results | |
| 2023-08-09 | Quarterly Results |
Brawn Biotech FAQs
What is Share Price of Brawn Biotech ?
Brawn Biotech share price is ₹21 As on 03 October, 2024 | 20:03
What is the Market Cap of Brawn Biotech ?
The Market Cap of Brawn Biotech is ₹6.4 Cr As on 03 October, 2024 | 20:03
What is the P/E ratio of Brawn Biotech ?
The P/E ratio of Brawn Biotech is -3.3 As on 03 October, 2024 | 20:03
What is the PB ratio of Brawn Biotech ?
The PB ratio of Brawn Biotech is 1.3 As on 03 October, 2024 | 20:03